Concepedia

Pei-Yu Kuo

PK

Statistics

Publications

5

Citations

144

H-Index

5

Active since

2013

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Albert Einstein College of Medicine

Pei-Yu Kuo is an author at Icahn School of Medicine at Mount Sinai specializing in tumor biology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2013–2016

5

Publications

5

High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma

Pei-Yu Kuo, Violetta V. Leshchenko, Melissa Fazzari et al. · Oncogene · 2014 · 63 citations · Full text

, , +9

Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma

Deepak Perumal, Pei-Yu Kuo, Violetta V. Leshchenko et al. · Cancer Research · 2016 · 31 citations · Full text

, , +14

Integrative Genomic Analysis of Temozolomide Resistance in Diffuse Large B-Cell Lymphoma

Violetta V. Leshchenko, Pei-Yu Kuo, Zewei Jiang et al. · Clinical Cancer Research · 2013 · 23 citations

Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma

Violetta V. Leshchenko, Pei-Yu Kuo, Zewei Jiang et al. · Oncotarget · 2015 · 17 citations · Full text

Weighted Gene Co-Expression Network Analysis (WGCNA) Identifies Highly Proliferative Myeloma Subgroup Responsive to CDK4/ARK5 Inhibition

Deepak Perumal, Violetta V. Leshchenko, Pei-Yu Kuo et al. · Blood · 2014 · 10 citations

1–5 of 5